Case of a sigmoid colon cancer with metachronous metastases to the mesorectum and the abdominal wall
© Kalaitzis et al. 2010
Received: 2 January 2010
Accepted: 21 March 2010
Published: 21 March 2010
Sigmoid colon cancer metachronous metastases commonly occur in the liver and lungs with sporadic reports also to the spleen, stomach, thyroid gland, abdominal wall and upper urinary tract. This is a rare case of metachronous metastases invading the mesorectum and the abdominal wall.
A 72-year-old female underwent sigmoidectomy for stage I (T2N0 M0) sigmoid colon cancer in May 2008. In June 2009, an abdominal computed tomography scan revealed a tumor 2 cm in size at the lower anterior mesorectum and a second mass 2 cm in size at the anterior abdominal wall midline. Total colonoscopy showed no mucosal lesion. The serum carcinoembryonic antigen level was normal. A biopsy of the mesorectum tumor showed similar histologic characteristics with the primary tumor. Since no other site of recurrence was identified, an abdominoperineal resection was attempted. During the operation and after the removal of the incision recurrence, sinus bradycardia and signs of myocardial ischemia were noticed. A loop transverse colostomy was immediately perfomed and the operation was terminated. Postoperative cardiologic examination revealed an acute myocardium infract. Chemo-radiation of the mesorectum tumor and re-evaluation for surgical excision was decided.
Metachronous metastasis of the mesorectum from sigmoid colon cancer is extremely rare. Although patterns of lymphatic spread from rectal cancer to sigmoid colon have recently been demonstrated, there is no evidence of metachronous mesorectum invasion from sigmoid colon cancer. This could be the issue for future trials.
Colon cancer as one of the most commonly diagnosed cancers around the world has an improved prognosis due to the development of diagnostic and therapeutic procedures. Overall survival however, can be seriously shortened, mostly in the presence of distant metastasis during follow-up. Liver is the commonest site of metachronous metastases in approximately one fourth of the patients, followed by the lungs . Sporadic reports also demonstrate the spleen, thyroid gland, stomach, urinary system and abdominal wall as sites of possible reccurence [2–4]. This is a rare case of a sigmoid colon cancer with metachronous metastases of the mesorectum and the abdominal wall.
Recurrence after curative resection of colon adenocarcinoma is a major determinant of survival and it seems to increase as the primary tumor stage advance. In this case, a sigmoid adenocarcinoma is infiltrating 2/3 of muscularis propria with four lymph nodes harvested free of metastatic disease. According to TNM classification this is a stage I (TIN0 M0) colon cancer but with inadequate lymph node evaluation [6–8]. Even though the literature lacks consensus as to what the exact number of lymph nodes by stage should be, a minimal number of twelve lymph nodes is recommended [9–13]. Nevertheless, metachronous metastasis to the mesorectum of a moderately differentiated T2 sigmoid adenocarcinoma with adequate peripheral surgical margin is extremely rare. The pathway tumor cells followed is unknown but one could suspect lymphatic spread. This is justified by the inadequate lymph node excision. But even if this is true, downward lymphatic flow is not common [14, 15]. Recently, lymphatic spread from rectal cancer to the sigmoid colon lymph nodes was demonstrated in as much as 20% . It seems that lymph flow is not only towards the paraortic lymph nodes but follows a more diffuse pattern. In addition, it is known that wound recurrence incidence is less than 1% and is probably a result of implanted cancer cells on the surgical wound during removal of the surgical specimen .
This case is important in showing that metachronous metastasis of the mesorectum from sigmoid colon cancer is possible, probably due to downward lymphatic cancer spread. Perhaps, there is a need of a more thorough investigation of the mesorectum region in sigmoid colon cancer during preoperative imaging. There is no similar report published in the literature.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
To AH and NP for their general contribution in writing this manuscript.
- Hoshino S, Yanauchi K, Mikami T, Shinohara T: Evaluation of risk factors for metachronous liver and lung metastasis in colorectal carcinoma. Med Bull Fukuoka Univ 2007, 34 (4) : 279–283.
- Rasim Gencosmanoglu, Fugen Aker, Gozde Kir, Nurdan Tozun: Isolated metachronous splenic metastasis from synchronous colon cancer. World J Surg Oncol 2006, 4: 42.View Article
- Shirakawa S, Kaneda K, Fujiwara H, Nishimura T, Sendo H, Wada T, Kizaki T: Case of a sigmoid colon cancer with metachronous metastases of the stomach and the abdominal wall. Nippon Shokakibyo Gakkai Zasshi 2009, 106 (5) : 653–9.PubMed
- Mesko TW, Friedman J, Sendzischew H, Nixon DD: Rectal carcinoma metastatic to the thyroid gland. J Laryngol Otol 1996, 110 (2) : 192–5.PubMedView Article
- Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998, 129 (1) : 27–35.PubMed
- NCCN Clinical Practice Guidelines in Oncology ColonCancer V.3.2009
- Compton CC, Greene FL: The staging of colorectal cancer: 2004 and beyond. Ca Cancer J Clin 2004, 54: 295–308.PubMedView Article
- International Union Against Cancer (UICC): Colon and rectum. In TNM classification of malignant tumors. 6th edition. Edited by: Sobin LH, Wittekind CH. New York, NY: Wiley; 2002:72–76.
- Compton CC, Fielding LP, Burgardt LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American pathologists consensus statement. Arch Pathol Lab Med 2000, 124: 979–994.PubMed
- Sobin HL, Greene FL: TNM classification. Clarification of number of regional lymph node for pN0. Cancer 2001, 92 (2) : 452.PubMedView Article
- Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG: Colon cancer survival is associated with increasing number of lunph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003, 21: 2912–2919.PubMedView Article
- Chaplin S, Scerottini G-P, Bosman F-T, Konstanda MT, Givel J-C: For patients with Duke's B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998, 83: 666–72.View Article
- Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, Catalano PJ, Haller DG: Accuracy of determining nodal negativity in colorectal cancer on the basis of number of nodes retrieved on resection.
- Kobayashi Y, Fujita S, Yamaguchi T, Yamamoto S, Akasu T, Moriya Y: Optimum lymph node dissection in clinical T1 and clinical T2 colorectal cancer. Dis Colon Rectum 2009, 52 (5) : 942–9.PubMed
- Canessa CE, Badía F, Fierro S, Fiol V, Háyek G: Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum 2001, 44 (9) : 1333–6.PubMedView Article
- Park IJ, Choi GS, Lim KH, Kang BM, Jun SH: Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer. Ann Surg 2009, 249: 960–964.PubMedView Article
- Reilly WT, Nelson H, Schroeder G, Wieand HS, Bolton J, O'Connell MJ: Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum 1996, 39 (2) : 200–7.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.